Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00014079 · ClinicalTrials.gov registry record
Genetic Markers in Patients With Colorectal Cancer
A clinical trial, sponsored by Alliance for Clinical Trials in Oncology.
- Completed
- Registry status
- 675
- Enrollment target
NCT00014079: Completed study, sponsored by Alliance for Clinical Trials in Oncology.
NCT00014079 is a clinical trial that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 675 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00014079 has completed, sponsored by Alliance for Clinical Trials in Oncology.
- COMPLETED
- Registry status
- 675 participants
- Enrollment target
Study Summary
RATIONALE: Determination of genetic markers for colorectal cancer may improve the identification of patients who are at highest risk for relapse. PURPOSE: This clinical trial is studying the importance of genetic markers for detecting relapse in patients with colorectal cancer.
Interventions
- GENETIC DNA stability analysis
- GENETIC microsatellite instability analysis
- GENETIC loss of heterozygosity analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 675 participants |
| Start Date | 1997-09 |
| Est. Completion | 2005-05 |
What the finished NCT00014079 record still lists
NCT00014079 is an observational study that tracks outcomes without assigning an intervention. The registered 675 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 3 interventions - of which DNA stability analysis is the first listed.
NCT00014079 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00014079 about?
NCT00014079 is a clinical study titled "Genetic Markers in Patients With Colorectal Cancer". RATIONALE: Determination of genetic markers for colorectal cancer may improve the identification of patients who are at highest risk for relapse. PURPOSE: This clinical trial is studying the importance of genetic markers for detecting relapse in patients with colorectal cancer.
What is the current status of trial NCT00014079?
This trial is currently completed. The enrollment target is 675 participants. The study started on 1997-09. Estimated completion is 2005-05.
What interventions are being tested in trial NCT00014079?
The interventions under investigation include: DNA stability analysis (GENETIC), microsatellite instability analysis (GENETIC), loss of heterozygosity analysis (GENETIC).
Who is sponsoring clinical trial NCT00014079?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04788277 · 675 participants
Investigation Into Detection of Prostate Cancer Using Voided Urine (Prostate VPAC)
- NCT05356234 · 675 participants · NA
Ignite Study of the Jewish Family and Children's Service of the Suncoast, Inc.
- NCT06070870 · 675 participants · NA
Health Education Approach to Lung Screening
- NCT06357533 · 675 participants · Phase 3
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia